Elizabeth Juarez
FDA investigator
Appears on 1 document from 2016, mostly at sites in California. Most often cites postmarketing reporting of adverse drug experiences (21 CFR 314.80).
- 1
- Documents on file
- 4.0
- Observations per 483
- 2016
- First seen
- 2016
- Most recent
What they cite most
From 4 observations- 21 CFR 314.80Postmarketing reporting of adverse drug experiences3
- 21 CFR 211.67Equipment cleaning and maintenance1
Activity by year
2016: 1
Where
California 1
Often inspects with
Is Elizabeth Juarez coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2016-05-04 | 483 Impax Laboratories, LLCMay 4, 2016 · Hayward, California | Hayward, California | 4 |
About this profile
What does Elizabeth Juarez inspect?
Elizabeth Juarez appears on 1 document on file covering 1 site, mostly in California.
What do they cite most often?
21 CFR 314.80 (postmarketing reporting of adverse drug experiences), followed by 21 CFR 211.67.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Elizabeth Juarez is dated May 4, 2016.